查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609990

酵素替代療法市場規模、佔有率、趨勢分析報告：按產品、治療疾病、給藥途徑、最終用途、地區和細分市場預測，2025-2030 年

Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Imiglucerase), By Therapeutic Condition (MPS), By Route Of Administration (Oral), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

酵素替代療法市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計到2030年，全球酵素替代療法市場規模將達到172.6億美元，2025年至2030年複合年成長率為9.0%。根據遺傳和罕見疾病資訊中心 (GARD) 的說法，罕見疾病被定義為影響人數少於 20 萬人的疾病。這些疾病也被稱為罕見疾病，因為它們以前沒有得到製藥公司的支持。自1983年美國《孤兒藥法案》通過以來，幾大製藥和生物製藥公司都大力投資孤兒藥的開發。因此，認知的提高、研發投資的增加、溶小體貯積症和遺傳疾病發生率的上升以及醫藥品認證過程的簡化是預測期內推動市場成長的因素。

美國衛生研究院的資料估計，超過 2500 萬美國患有罕見疾病。這些事實表明，這些疾病雖然數量不多，但受影響的人數卻很大。採用酵素替代療法最常見的溶小體貯積症包括戈謝氏症、法布氏症候群、龐貝氏症候群、MPS、SCID 和 Shwachman-Diamond 症候群。

近年來，這些疾病受到高度關注，並對生長產生積極影響。制定了各種津貼和法律，使藥品製造商能夠投資於罕見疾病藥物的開發。孤兒藥審查指定計劃、罕見兒科疾病優先審查券計劃、人道主義使用設備 (HUD) 計劃和孤兒產品臨床測試津貼計劃是支持孤兒藥開發的計劃。

居家醫療和輸液中心擴大使用酵素替代療法正在推動市場發展。預計此類專業輸液中心在預測期內的複合年成長率最高。由於醫院交通便利且能夠治療多種疾病，因此佔據了最大的市場。

酵素替代療法市場報告亮點

  • 高雪氏症在市場上佔據主導地位，2024年佔最大銷售佔有率，達32.6%。
  • 伊米苷酶佔據市場主導地位，2024 年佔最大銷售佔有率，達 20.2%。這是因為高雪氏症的盛行率正在增加，需要有效的治療方案。此外，隨著認知和診斷率的提高，越來越多的患者被識別出來，對伊米苷酶的需求也在增加。
  • 腸外用藥佔據市場主導地位，2024 年佔最大銷售佔有率，達 80.9%。這種成長歸因於其促進快速吸收和有效藥物輸送的能力。此外，這種方法允許靜脈注射，這對於將酶等大分子直接輸送到血液中至關重要，以確保立即產生治療效果。
  • 輸液中心引領市場，2024 年佔最大銷售佔有率，達 40.8%。這些中心提供受控環境來實施 ERT，確保患者在輸注期間的安全和舒適。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章酵素替代療法市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章酵素替代療法市場：產品業務分析

  • 2024年及2030年產品市場佔有率
  • 產品細分儀表板
  • 2018-2030 年按產品分類的市場規模、預測與趨勢分析
  • 伊米苷酶
  • 阿加糖酶BETA
  • 塔利葡萄糖酶
  • 維拉苷酶α
  • 聚乙二醇酶
  • 拉羅尼酶
  • 胰酶
  • 艾杜硫酶
  • 半乳糖酶
  • 其他

第5章酵素替代療法市場：治療疾病業務分析

  • 2024年及2030年疾病治療市場佔有率
  • 治療疾病細分儀表板
  • 2018-2030 年按治療疾病分類的市場規模、預測與趨勢分析
  • 高雪氏症
  • 多夫
  • SCID
  • 龐貝氏症
  • 法布瑞氏症
  • 其他

第6章酵素替代療法市場：給藥途徑業務分析

  • 2024 年及 2030 年給藥途徑市場佔有率
  • 細分儀表板
  • 2018-2030 年按管理方式分類的市場規模、預測與趨勢分析
  • 胃腸外的
  • 口服

第7章酵素替代療法市場：最終用途業務分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 2018-2030 年按最終用途分類的市場規模、預測與趨勢分析
  • 點滴中心
  • 醫院
  • 其他

第8章酵素替代療法市場：產品、治療疾病、最終用途、區域、估計和趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • Carl Zeiss Meditec, Inc.
    • 夏爾公司，
    • Sanofi SA
    • Biomarin Pharmaceutical Inc.
    • AbbVie
    • Alexion Pharmaceuticals Inc.
    • Allergan plc
    • Horizon Pharma Public Limited Company
    • Actelion（Janssen）
    • Recordati Rare Diseases
    • Protalix BIoTherapeutics
    • Amicus Therapeutics, Inc.
Product Code: GVR-3-68038-999-9

Enzyme Replacement Therapy Market Growth & Trends:

The global enzyme replacement therapy market size is estimated to reach USD 17.26 billion by 2030, registering to grow at a CAGR of 9.0% from 2025 to 2030 according to a new report by Grand View Research, Inc. As per the Genetic and Rare Diseases Information Center or GARD, a rare disease is defined as a condition that affects lesser than 200,000 individuals. These disorders are also called orphan diseases due to the lack of support exhibited by pharmaceutical companies previously. Since the passing of the Orphan Drug Act of 1983 in the U.S., several large pharmaceutical and biopharmaceutical companies have invested heavily in the development of orphan drugs. Thus, rising awareness, increasing R&D investment, growth in the number of lysosomal storage and genetic disorders, and easy drug approval process are factors propelling the market growth during the forecast period.

According to data from the National Institutes of Health, it is estimated that over 25 million Americans suffer from rare diseases. These facts are indicative of the fact that although the number of these ailments is low, individuals suffering from these are large. Some of the most common lysosomal storage disorders that make use of enzyme replacement therapy are Gaucher, Fabry, Pompe, MPS, SCID, and Shwachman-Diamond Syndrome among others.

In the recent past, these disorders have been gaining significant attention, impacting growth positively. Various grants and acts are in place to accommodate drug makers to invest in the development of orphan drugs. Orphan Drug Designation Program, Rare Pediatric Disease Priority Review Voucher Program, Humanitarian Use Device (HUD) Program, and Orphan Products Clinical Trials Grants Program are programs that aid in the development of orphan drugs.

The rising use of enzyme replacement therapy in home care and infusion centers are gaining traction in the market. Specialized infusion centers such as these are anticipated to witness the highest CAGR during the forecast period. Hospitals held the largest segmental share owing to easy accessibility and ability to treat a wide range of ailments.

Enzyme Replacement Therapy Market Report Highlights:

  • Gaucher disease held the dominant position in the market and accounted for the largest revenue share of 32.6% in 2024, driven by the increasing prevalence and awareness of the condition, leading to more patients being diagnosed and treated.
  • Imiglucerase dominated the market and accounted for the largest revenue share of 20.2% in 2024, owing to the rising prevalence of Gaucher disease, which necessitates effective treatment options. In addition, as awareness and diagnosis rates improve, more patients are being identified, increasing demand for imiglucerase.
  • The parenteral route of administration dominated the market and accounted for the largest revenue share of 80.9% in 2024. This growth is attributed to its ability to facilitate rapid absorption and effective drug delivery. In addition, this method allows for intravenous infusions, which are essential for delivering large molecules such as enzymes directly into the bloodstream, ensuring immediate therapeutic effects
  • Infusion centers led the market and accounted for the largest revenue share of 40.8% in 2024, driven by their specialized focus on intravenous treatments. These centers provide a controlled environment for administering ERT, ensuring patient safety and comfort during infusions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Therapeutic Condition
    • 1.2.3. Route of Administration
    • 1.2.4. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Enzyme Replacement Therapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Enzyme Replacement Therapy Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Imiglucerase
    • 4.4.1. Imiglucerase Market, 2018 - 2030 (USD Million)
  • 4.5. Agalsidase Beta
    • 4.5.1. Agalsidase Beta Market, 2018 - 2030 (USD Million)
    • 4.5.2. Alglucosidase Alfa
    • 4.5.3. Alglucosidase Alfa Market, 2018 - 2030 (USD Million)
  • 4.6. Taliglucerase
    • 4.6.1. Taliglucerase Market, 2018 - 2030 (USD Million)
  • 4.7. Velaglucerase Alfa
    • 4.7.1. Velaglucerase Alfa Market, 2018 - 2030 (USD Million)
  • 4.8. Pegademase
    • 4.8.1. Pegademase Market, 2018 - 2030 (USD Million)
  • 4.9. Laronidase
    • 4.9.1. Laronidase Market, 2018 - 2030 (USD Million)
  • 4.10. Pancreatic Enzymes
    • 4.10.1. Pancreatic Enzymes Market, 2018 - 2030 (USD Million)
  • 4.11. Idursulfase
    • 4.11.1. Idursulfase Market, 2018 - 2030 (USD Million)
  • 4.12. Galsulfase
    • 4.12.1. Galsulfase Market, 2018 - 2030 (USD Million)
  • 4.13. Others
    • 4.13.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Enzyme Replacement Therapy Market: Therapeutic Condition Business Analysis

  • 5.1. Therapeutic Condition Market Share, 2024 & 2030
  • 5.2. Therapeutic Condition Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Condition, 2018 to 2030 (USD Million)
  • 5.4. Gaucher Disease
    • 5.4.1. Gaucher Disease Market, 2018 - 2030 (USD Million)
  • 5.5. MPS
    • 5.5.1. MPS Market, 2018 - 2030 (USD Million)
  • 5.6. SCID
    • 5.6.1. SCID Market, 2018 - 2030 (USD Million)
  • 5.7. Pompe Disease
    • 5.7.1. Pompe Disease Market, 2018 - 2030 (USD Million)
  • 5.8. Fabry Disease
    • 5.8.1. Fabry Disease Market, 2018 - 2030 (USD Million)
  • 5.9. Other
    • 5.9.1. Other Market, 2018 - 2030 (USD Million)

Chapter 6. Enzyme Replacement Therapy Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Parenteral
    • 6.4.1. Parenteral Market, 2018 - 2030 (USD Million)
  • 6.5. Oral
    • 6.5.1. Oral Market, 2018 - 2030 (USD Million)

Chapter 7. Enzyme Replacement Therapy Market: End Use Business Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Infusion Centers
    • 7.4.1. Infusion Centers Market, 2018 - 2030 (USD Million)
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.6. Other
    • 7.6.1. Other Market, 2018 - 2030 (USD Million)

Chapter 8. Enzyme Replacement Therapy Market: Regional Estimates & Trend Analysis by Product, Therapeutic Condition, and End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamic
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamic
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamic
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamic
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamic
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamic
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamic
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamic
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamic
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamic
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamic
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamic
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamic
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamic
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamic
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamic
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamic
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamic
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamic
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamic
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamic
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamic
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamic
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Enzyme Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Carl Zeiss Meditec, Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Shire Plc;
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3 Sanofi S.A.
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.4. Biomarin Pharmaceutical Inc.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. AbbVie
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Alexion Pharmaceuticals Inc.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Allergan plc
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Horizon Pharma Public Limited Company
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Actelion (Janssen)
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Recordati Rare Diseases
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives
    • 9.5.11. Protalix Biotherapeutics
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial Performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic Initiatives
    • 9.5.12. Amicus Therapeutics, Inc.
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial Performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Enzyme Replacement Therapy Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 5. Global Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 6. Global Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7. Global Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. North America Enzyme Replacement Therapy Market, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 10. North America Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 11. North America Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12. North America Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 14. U.S. Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 15. U.S. Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 16. U.S. Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Canada Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 18. Canada Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 19. Canada Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 20. Canada Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Mexico Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 22. Mexico Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 23. Mexico Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24. Mexico Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25. Europe Enzyme Replacement Therapy Market, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 27. Europe Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 28. Europe Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 29. Europe Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30. UK Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 31. UK Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 32. UK Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 33. UK Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34. Germany Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 35. Germany Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 36. Germany Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 37. Germany Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38. France Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 39. France Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 40. France Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41. France Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Italy Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 43. Italy Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 44. Italy Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 45. Italy Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Spain Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 47. Spain Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 48. Spain Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 49. Spain Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50. Norway Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 51. Norway Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 52. Norway Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53. Norway Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Denmark Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 55. Denmark Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 56. Denmark Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 57. Denmark Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Sweden Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 59. Sweden Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 60. Sweden Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61. Sweden Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Enzyme Replacement Therapy Market, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67. Japan Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 68. Japan Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 69. Japan Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 70. Japan Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71. China Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 72. China Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 73. China Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74. China Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75. India Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 76. India Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 77. India Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 78. India Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79. Australia Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 80. Australia Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 81. Australia Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82. Australia Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83. South Korea Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 84. South Korea Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 85. South Korea Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 86. South Korea Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Thailand Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 88. Thailand Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 89. Thailand Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90. Thailand Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91. Latin America Enzyme Replacement Therapy Market, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 93. Latin America Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 94. Latin America Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 95. Latin America Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96. Brazil Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 97. Brazil Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 98. Brazil Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 99. Brazil Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 101. Argentina Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 102. Argentina Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 103. Argentina Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Enzyme Replacement Therapy Market, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 110. South Africa Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 111. South Africa Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 112. South Africa Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117. UAE Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 118. UAE Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 119. UAE Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 120. UAE Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Enzyme Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Enzyme Replacement Therapy Market, by Therapeutic Condition, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Enzyme Replacement Therapy Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Enzyme Replacement Therapy Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Enzyme Replacement Therapy Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Product, Therapeutic Condition, Route of Administration and End Use Outlook (USD Million)
  • Fig. 10 Product, Therapeutic Condition, Route of Administration, and End Use Outlook
  • Fig. 11 Competitive Landscape
  • Fig. 12 Enzyme Replacement Therapy Market Dynamics
  • Fig. 13 Enzyme Replacement Therapy Market: Porter's Five Forces Analysis
  • Fig. 14 Enzyme Replacement Therapy Market: PESTLE analysis
  • Fig. 15 Enzyme Replacement Therapy Market: Product Segment Dashboard
  • Fig. 16 Enzyme Replacement Therapy Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 17 Imiglucerase Market, 2018 - 2030 (USD Million)
  • Fig. 18 Agalsidase Beta Market, 2018 - 2030 (USD Million)
  • Fig. 19 Alglucosidase Alfa Market, 2018 - 2030 (USD Million)
  • Fig. 20 Taliglucerase Market, 2018 - 2030 (USD Million)
  • Fig. 21 Velaglucerase Alfa Market, 2018 - 2030 (USD Million)
  • Fig. 22 Pegademase Market, 2018 - 2030 (USD Million)
  • Fig. 23 Laronidase Market, 2018 - 2030 (USD Million)
  • Fig. 24 Pancreatic Enzymes Market, 2018 - 2030 (USD Million)
  • Fig. 25 Idursulfase Market, 2018 - 2030 (USD Million)
  • Fig. 26 Galsulfase Market, 2018 - 2030 (USD Million)
  • Fig. 27 Others Market, 2018 - 2030 (USD Million)
  • Fig. 28 Enzyme Replacement Therapy Market: Therapeutic Condition Segment Dashboard
  • Fig. 29 Enzyme Replacement Therapy Market: Therapeutic Condition Market Share Analysis, 2024 & 2030
  • Fig. 30 Gaucher Disease Market, 2018 - 2030 (USD Million)
  • Fig. 31 MPS Market, 2018 - 2030 (USD Million)
  • Fig. 32 SCID Market, 2018 - 2030 (USD Million)
  • Fig. 33 Pompe Disease Market, 2018 - 2030 (USD Million)
  • Fig. 34 Fabry Disease Market, 2018 - 2030 (USD Million)
  • Fig. 35 Other Market, 2018 - 2030 (USD Million)
  • Fig. 36 Enzyme Replacement Therapy Market: Route of Administration Segment Dashboard
  • Fig. 37 Enzyme Replacement Therapy Market: Route of Administration Market Share Analysis, 2024 & 2030
  • Fig. 38 Parenteral Market, 2018 - 2030 (USD Million)
  • Fig. 39 Oral Market, 2018 - 2030 (USD Million)
  • Fig. 40 Enzyme Replacement Therapy Market: End Use Segment Dashboard
  • Fig. 41 Enzyme Replacement Therapy Market: End Use Market Share Analysis, 2024 & 2030
  • Fig. 42 Infusion Centers Market, 2018 - 2030 (USD Million)
  • Fig. 43 Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 44 Other Market, 2018 - 2030 (USD Million)
  • Fig. 45 Enzyme Replacement Therapy Market Revenue, By Region
  • Fig. 46 Regional Marketplace: Key Takeaways
  • Fig. 47 Regional Marketplace: Key Takeaways
  • Fig. 48 North America Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 49 U.S. Country Dynamics
  • Fig. 50 U.S. Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 51 Canada Country Dynamics
  • Fig. 52 Canada Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico Country Dynamics
  • Fig. 54 Mexico Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 55 Europe Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 56 UK Country Dynamics
  • Fig. 57 UK Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 58 Germany Country Dynamics
  • Fig. 59 Germany Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 60 France Country Dynamics
  • Fig. 61 France Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 62 Italy Country Dynamics
  • Fig. 63 Italy Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 64 Spain Country Dynamics
  • Fig. 65 Spain Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 66 Norway Country Dynamics
  • Fig. 67 Norway Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 68 Sweden Country Dynamics
  • Fig. 69 Sweden Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 70 Denmark Country Dynamics
  • Fig. 71 Denmark Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 73 Japan Country Dynamics
  • Fig. 74 Japan Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 75 China Country Dynamics
  • Fig. 76 China Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 77 India Country Dynamics
  • Fig. 78 India Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia Country Dynamics
  • Fig. 80 Australia Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea Country Dynamics
  • Fig. 82 South Korea Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 83 Thailand Country Dynamics
  • Fig. 84 Thailand Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 85 Latin America Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 86 Brazil Country Dynamics
  • Fig. 87 Brazil Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 88 Argentina Country Dynamics
  • Fig. 89 Argentina Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 90 MEA Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa Country Dynamics
  • Fig. 92 South Africa Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia Country Dynamics
  • Fig. 94 Saudi Arabia Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 95 UAE Country Dynamics
  • Fig. 96 UAE Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait Key Country Dynamics
  • Fig. 98 Kuwait Enzyme Replacement Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 99 Company Categorization
  • Fig. 100 Company Market Position Analysis
  • Fig. 101 Strategic Framework